StockData
InspireMD, Inc. logo

InspireMD, Inc. (NSPR) stock

NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3057% below fair value
$0.60−0.04 (-6.85%)

Close on Nov 16, 2026Market cap $27.89MP/E –Yield –

InspireMD price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

InspireMD's price to sales ratio was 3.5× on Nov 11, 2026, against 10.7× a year earlier. Over the last 5 years it ranged from 1.3× to 14.0×, with a median of 8.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.5×−6.1
2025Dec 31, 20259.6×−0.3
2024Dec 31, 20249.9×−1.1
2023Dec 29, 202311.0×+9.7
2022Dec 30, 20221.3×−6.0
2021Dec 31, 20217.3×+3.6
2020Dec 31, 20203.7×+2.6
2019Dec 31, 20191.1×−0.6
2018Dec 31, 20181.6×+1.2
2017Dec 29, 20170.4×−1.2
2016Dec 30, 20161.6×+0.2
2015Dec 31, 20151.4×−3.8
2014Dec 31, 20145.3×−11.3
2013Dec 31, 201316.6×+6.2
2012Dec 31, 201210.3×−12.8
2011Dec 30, 201123.1×–

More InspireMD figures

See a number that looks wrong?